Texaclear Mold Mix Allergy Relief Liquid
NDC Package 58809-219-02

11-digit billing NDC: 58809021902
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Texaclear Mold Mix Allergy Relief (alternaria alt, aspergillus fum, aspergillus nig, aureobasidium pul, bipolaris sor, boletus sat, botrytis cin, candida alb, cladosporium clad, epicoccum nig, gibberella pul, mucor plu, rhodotorula muc, saccharomyces cer, trichophyton men, ustilago may, histaminum, baptisia tinctoria, echinacea, hydrastis canadensis, myrrha, nasturtium aquaticum, phytolacca decandra, urtica urens) liquids is uses: Temporarily relieves sneezing, runny nose, itchy, watery eyes, and nasal congestion associated with mold.*. This formulation utilizes a liquid delivery system. Marketed by Gm Pharmaceuticals, Inc, this product is identified by NDC 58809-219.

Identification & Billing

NDC Package Code
58809-219-02
Package Description
59.1 mL in 1 BOTTLE, DROPPER
Product Code
58809-219
11-Digit Billing Format
58809021902

Clinical Specifications

Proprietary Name
Texaclear Mold Mix Allergy Relief
Non-Proprietary Name
Alternaria Alt, Aspergillus Fum, Aspergillus Nig, Aureobasidium Pul, Bipolaris Sor, Boletus Sat, Botrytis Cin, Candida Alb, Cladosporium Clad, Epicoccum Nig, Gibberella Pul, Mucor Plu, Rhodotorula Muc, Saccharomyces Cer, Trichophyton Men, Ustilago May, Histaminum, Baptisia Tinctoria, Echinacea, Hydrastis Canadensis, Myrrha, Nasturtium Aquaticum, Phytolacca Decandra, Urtica Urens
Substance Name
Alternaria Alternata; Aspergillus Fumigatus; Aspergillus Niger Var. Niger; Boletus Satanas Fruiting Body; Botrytis Cinerea; Passalora Fulva; Fusarium Oxysporum; Cochliobolus Sativus; Aureobasidium Pullulans Var. Pullutans; Ustilago Maydis; Histamine Dihydrochloride; Saccharomyces Cerevisiae; Cladosporium Cladosporioides; Epicoccum Nigrum; Mucor Racemosus; Rhodotorula Rubra; Trichophyton Mentagrophytes; Baptisia Tinctoria Root; Echinacea Angustifolia Root; Goldenseal; Myrrh; Nasturtium Officinale; Phytolacca Americana Root; Urtica Urens
Dosage Form
Liquid - A dosage form consisting of a pure chemical in its liquid1 state. This dosage form term should not be applied to solutions.
Administration Route
Sublingual - Administration beneath the tongue.
Active Ingredient(s)
Pharmacologic Class
Usage Information
Uses: Temporarily relieves sneezing, runny nose, itchy, watery eyes, and nasal congestion associated with mold.*

Regulatory & Marketing

Labeler Name
Gm Pharmaceuticals, Inc
Product Type
Human Otc Drug
Marketing Category
UNAPPROVED HOMEOPATHIC - A category specifying that a product is marketed as unapproved homeopathic product.
Start Marketing Date
09-20-2026
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 58809-219-02 identifies a specific commercial package of 59.1 ml in 1 bottle, dropper of Texaclear Mold Mix Allergy Relief, a human over the counter drug labeled by Gm Pharmaceuticals, Inc. This liquid is formulated for sublingual use and contains alternaria alternata; aspergillus fumigatus; aspergillus niger var. niger; boletus satanas fruiting body; botrytis cinerea; passalora fulva; fusarium oxysporum; cochliobolus sativus; aureobasidium pullulans var. pullutans; ustilago maydis; histamine dihydrochloride; saccharomyces cerevisiae; cladosporium cladosporioides; epicoccum nigrum; mucor racemosus; rhodotorula rubra; trichophyton mentagrophytes; baptisia tinctoria root; echinacea angustifolia root; goldenseal; myrrh; nasturtium officinale; phytolacca americana root; urtica urens as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Gm Pharmaceuticals, Inc on September 20, 2026. The current certification is valid through December 31, 2027.

How is this Gm Pharmaceuticals, Inc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 58809021902. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
58809-219-02
11-Digit CMS (5-4-2)
58809-0219-02

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.